Updates in the management of heart failure for the chronic kidney disease patient.

ABSTRACT:

Purpose of review

Heart failure is highly prevalent in patients with chronic kidney disease (CKD) and a leading cause of morbidity and mortality in this population. Heart failure therapies proven to benefit the general population may have different risk-benefit profiles in patients with concurrent CKD, plausibly because of the unique pathophysiology of heart failure in this population. The present review highlights recent advances in heart failure treatment as they apply to patients with CKD.

Recent findings

Several recent publications have shown possible benefits of established heart failure therapies to improve clinical outcomes in patients with CKD; while others conclude neutral or even harmful effects of heart failure therapies in CKD patients. Novel heart failure therap

SUBMITTER: Hsu S 

PROVIDER: S-EPMC6625663 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature